Haleon (LON:HLN) Now Covered by HSBC

HSBC initiated coverage on shares of Haleon (LON:HLN) in a report issued on Thursday, MarketBeat Ratings reports. The firm issued a buy rating on the stock.

Separately, Barclays cut their price objective on shares of Haleon from GBX 390 ($4.85) to GBX 383 ($4.77) and set an overweight rating on the stock in a research report on Tuesday, April 9th.

Haleon Stock Performance

HLN stock opened at GBX 325.80 ($4.06) on Thursday. The company has a debt-to-equity ratio of 57.42, a quick ratio of 0.93 and a current ratio of 1.04. The stock has a market cap of £29.75 billion and a P/E ratio of 2,961.82. The firm has a 50 day simple moving average of GBX 324.40 and a 200 day simple moving average of GBX 326.52. Haleon has a 52 week low of GBX 306.80 ($3.82) and a 52 week high of GBX 357.65 ($4.45).

Haleon Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, May 16th. Investors of record on Thursday, March 14th will be given a dividend of GBX 4.20 ($0.05) per share. This represents a yield of 1.34%. The ex-dividend date of this dividend is Thursday, March 14th. This is a positive change from Haleon’s previous dividend of $1.80. Haleon’s dividend payout ratio (DPR) is presently 5,454.55%.

Insider Activity at Haleon

In other news, insider Tobias Hestler sold 23,564 shares of Haleon stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of GBX 329 ($4.10), for a total value of £77,525.56 ($96,508.85). Insiders own 22.53% of the company’s stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.